Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer
Year: 2024
Type: erratum
Abstract: [Image: see text]
Source: EMBO Molecular Medicine
Authors: Christopher W Schultz, Yang Zhang, Rajaa Elmeskini, Astrid Zimmermann, Haiqing Fu, Yasuhisa Murai, Darawalee Wangsa, Suresh Kumar, Nobuyuki Takahashi, Devon Atkinson, Liton Kumar Saha, Chien-Fei Lee, Brian Elenbaas, Parth Desai, Robin Sebastian, Ajit Kumar Sharma, Melissa Abel, Brett Schroeder, Manan Krishnamurthy, Laurel L Bassel, Rajesh Kumar, Nitin Roper, Mirit Aladjem, Frank T Zenke, Zoe Weaver Ohler, Yves Pommier, Anish Thomas
Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. (United States), Merck KGaA, Darmstadt (Germany), National Center for Global Health and Medicine, EMD Serono, Inc. (United States), Merck Healthcare KGaA, Darmstadt (Germany)
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $6,890
OpenAlex ID: W4391882895